Oncology

Aloxi: new antiemetic for cancer patients

Drug is the fourth 5-HT3 antagonist to be marketed in Canada.
Inlyta for metastatic renal cell carcinoma

Drug is the fourth kinase inhibitor to be approved for treatment of metastatic renal cell carcinoma in Canada.
A champion of women’s health in Bangladesh

With the help of a little technology, Dr. Ophira Ginsburg is aiming to improve breast cancer care in a region where the disease is stigmatized
Is it time for lung cancer screening?

U.S. review says low-dose CT may be appropriate for some patients, but Canadian physicians are working on their own approach
Survivorship pioneers

First of its kind NP-led primary care clinic for colorectal cancer survivors another big step forward for a rapidly growing profession. Is this the survivorship model of the future?
Headway made against multiple myeloma

New treatments put the condition on track to become a chronic disease
Nurse researcher uses Nintendo Wii to address cancer-related fatigue

Amy Hoffman aims to help lung cancer patients reduce fatigue and get more exercise as they transition from the hospital to the home after surgery.
Jakavi: new drug for myelofibrosis

Myelofibrosis is a chronic, debilitating myeloproliferative disorder characterized by progressive anemia, bone marrow fibrosis, splenomegaly, and constitutional symptoms.

Free made-in-Canada software poised to reform breast-cancer screening and diagnosis